课题基金 / 基金详情

A proof-of-concept randomized controlled trial to show that the antidepressant effects of psilocybin do not require psychedelic effects

A proof-of-concept randomized controlled trial to show that the antidepressant effects of psilocybin do not require psychedelic effects
一项概念验证随机对照试验表明裸盖菇素的抗抑郁作用不需要迷幻作用
批准号:
461579
负责人:
Husain Muhammad I
金额:
$39.85万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2025-03-01

项目摘要

项目成果

Husain Muhammad I的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One third of patients with major depressive disorder (MDD) do not respond to conventional treatments and experience treatment-resistant depression (TRD). There has been a resurgence of interest on the use of psychedelics as novel treatments for mental dis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Culturally adapted psychoeducation (CaPE) for bipolar disorder in a low-resource setting: a randomized controlled trial
海外基金